Cargando…
Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop
On May 19, 2016, the US Food and Drug Administration (FDA) hosted a public workshop, entitled “Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation.”1 The topic of mechanistic oral absorption modeling, which is one of the major applications of...
Autores principales: | Zhang, X, Duan, J, Kesisoglou, F, Novakovic, J, Amidon, GL, Jamei, M, Lukacova, V, Eissing, T, Tsakalozou, E, Zhao, L, Lionberger, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572334/ https://www.ncbi.nlm.nih.gov/pubmed/28571121 http://dx.doi.org/10.1002/psp4.12204 |
Ejemplares similares
-
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview
por: Babiskin, Andrew, et al.
Publicado: (2023) -
Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations
por: Wang, Lu, et al.
Publicado: (2023) -
Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015) -
Physiologically‐based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%
por: Tsakalozou, Eleftheria, et al.
Publicado: (2021) -
Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence
por: Zhang, X, et al.
Publicado: (2017)